Table of Content

Global Bioelectronic Medicine Market -2018-2028F
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
4.1. By Type of Product
4.2. By Type of Technique
4.3. Type of Application for Which Bioelectronic Medicines Are Used
4.4. Factors Driving Market Growth
5. Global Bioelectronic Medicine Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Implantable v/s Non-invasive)
5.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
5.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson’s disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
5.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
5.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.6. By Company (2022)
5.3. Market Map
5.3.1. By Type
5.3.2. By Product
5.3.3. By Application
5.3.4. By End User
5.3.5. By Region
6. North America Bioelectronic Medicine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Implantable v/s Non-invasive)
6.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
6.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson’s disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
6.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Bioelectronic Medicine Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Product
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2. Canada Bioelectronic Medicine Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Product
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3. Mexico Bioelectronic Medicine Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Product
6.3.3.2.3. By Application
6.3.3.2.4. By End User
7. Europe Bioelectronic Medicine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Implantable v/s Non-invasive)
7.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
7.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson’s disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
7.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Bioelectronic Medicine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Product
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. Germany Bioelectronic Medicine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Product
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. United Kingdom Bioelectronic Medicine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Product
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. Italy Bioelectronic Medicine Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Product
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. Spain Bioelectronic Medicine Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Product
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. Asia-Pacific Bioelectronic Medicine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Implantable v/s Non-invasive)
8.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
8.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson’s disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
8.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Bioelectronic Medicine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Product
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. India Bioelectronic Medicine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Product
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. Japan Bioelectronic Medicine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Product
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. South Korea Bioelectronic Medicine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Product
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Australia Bioelectronic Medicine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Product
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. South America Bioelectronic Medicine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (Implantable v/s Non-invasive)
9.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
9.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson’s disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
9.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Bioelectronic Medicine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Product
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. Argentina Bioelectronic Medicine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Product
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. Colombia Bioelectronic Medicine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Product
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. Middle East and Africa Bioelectronic Medicine Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type (Implantable v/s Non-invasive)
10.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
10.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson’s disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
10.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Bioelectronic Medicine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Product
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Bioelectronic Medicine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Product
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. UAE Bioelectronic Medicine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Product
10.3.3.2.3. By Application
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
13. Clinical Trial Analysis
13.1. Ongoing Clinical Trials
13.2. Completed Clinical Trials
13.3. Terminated Clinical Trials
13.4. Breakdown of Pipeline, By Development Phase
13.5. Breakdown of Pipeline, By Status
13.6. Breakdown of Pipeline, By Study Type
13.7. Breakdown of Pipeline, By Region
13.8. Clinical Trials Heat Map
14. Global Bioelectronic Medicine Market: SWOT Analysis
15. Porter’s Five Forces Analysis
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products
16. Competitive Landscape
16.1. Business Overview
16.2. Product Offerings
16.3. Recent Developments
16.4. Financials (As Reported)
16.5. Key Personnel
16.6. SWOT Analysis
16.6.1. Medtronic plc.
16.6.2. Abbott Laboratories, Inc.
16.6.3. Boston Scientific Corporation.
16.6.4. Cochlear Ltd.
16.6.5. LivaNova PLC.
16.6.6. Soterix Medical Inc.
16.6.7. Bioinduction Ltd.
16.6.8. GiMer Medical.
16.6.9. Cefaly.
16.6.10. BioControl Medical.
17. Strategic Recommendations